Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Pulmatrix, Inc. (PULM)

1.5100 +0.0300 (+2.03%)
At close: August 28 at 4:00:00 PM EDT
1.4700 +0.0100 (+0.68%)
After hours: August 28 at 4:10:04 PM EDT
Chart Range Bar
Loading chart for PULM
  • Previous Close 1.4800
  • Open 1.4900
  • Bid 1.4700 x 500
  • Ask 1.6000 x 100
  • Day's Range 1.4584 - 1.5100
  • 52 Week Range 1.1600 - 5.4980
  • Volume 3,301
  • Avg. Volume 47,334
  • Market Cap (intraday) 5.515M
  • Beta (5Y Monthly) 1.92
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1100
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.

www.pulmatrix.com

2

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 8/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PULM
32.29%
S&P 500 (^GSPC)
12.65%

1-Year Return

PULM
69.56%
S&P 500 (^GSPC)
18.61%

3-Year Return

PULM
38.87%
S&P 500 (^GSPC)
73.95%

5-Year Return

PULM
90.77%
S&P 500 (^GSPC)
71.02%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY23
Revenue 1.75M
Earnings -3.77M
Profit Margin -215.29%

Q3

FY22

Q4

FY22

Q2

FY23

Q3

FY23

-4M
-2M
0
-260.0%
-240.0%
-220.0%

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    5.55M

  • Enterprise Value

    -3.97M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.46k

  • Price/Book (mrq)

    3.49

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -54.69%

  • Return on Equity (ttm)

    -98.35%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -4.03M

  • Diluted EPS (ttm)

    -1.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.17M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3.17M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.5100 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: